̷ A ̷(hepatitis A virus, HAV) ϴ ַ · Ÿ.
A B ̳ C Ǵ ƴ϶ A ̷ ̳ ν ȴ. Ư ߺ, ֱٿ ȯ濡 ڶ 20~30뿡 ߺ ϴ δ. ַ A ̷ ȯڿ 쿡 Ǹ, ƴ A ִ ü ϴ ¾ƿ ְ, ؼ Ǵ 汸 ؼ ִ. κ 뺯 ̳ ϸ鼭 汸 Ǹ, ߺϴ ļ̳ ̴.
A ̷ Ǹ 30 ẹ Ŀ Ƿΰ̳ , , Ŀ, ߿, Ÿ. ̳ Ư¡ Ȳ ¡İ Ÿµ, Һ(ݶ Һ), Ż 뺯 شȴ. Ȳ ϰ Ǹ Ÿ Ǹ, Ȳ 2 ӵȴ. Ҿƿ ̰ų, Ÿ ν ϰ 찡 .
Ÿ ̳ Ȳ Ÿ Ư¡ ӻ A ǽ ְ, A ü ˻縦 Ȯ ִ.
˻
A ̷(anti-HAV: anti- hepatitis A virus) ü ˻縦 A ִµ, A ̷ 鿪۷κҸM(IgM anti-HAV)ü˻翡 缺 Ÿ, Ư¡ ӻ ¡ĸ δٸ Ȯ ִ. A ̷ IgM ü Ÿ ƿ ȸ 6 ˻ 缺 Ÿ ִ. A ̷ 鿪۷κҸG(IgG anti-HAV)ü ȸ 缺 Ÿ, Ⱓ 缺 ȴ. Ȳ ˻翡 ƹ̳ȿ(aminotransferase) ġ 1000 ̻ Ǵ 찡 ְ, ˶ ƹ̳ȿ(alanine aminotransferase:ALT,GPT)ġ ƽĶ ƹ̳ȿ(aspartate aminotransferase:AST, GOT)ġ ξ ϰ ȴ. Ȳ ϴ û (bilirubin)ġ 밳 10 ̻ ϸ, Ÿ ġ Ѵ.
ġ
A ̷ ġϴ ߵ ʾҴ. Ϲ ȭŰ ֵ ġ̸, ܹ ̿ ִ ġῡ ȴ. ϴ 쿡 Կ ġḦ Ͽ ȭֱ Ѵ.
/պ
A ɸ κ ó ΰ 20 ̻ ο ߵǰ ̻ Կ̳ ؾ ϴ ɰ Ÿ ִ. ֱ ο Ÿ A ɰ 찡 . A 85% 3 ̳ ӻ, ȸǸ, B ̳ C ȭ ʰ κ ȸȴ. ϰų, B , C ȯ ϰ ִ 쿡 ӵ ȭǾ ݼ ɰ ʷϰ ȴ.
A ִ. Ŀ 6~12 ij 6~18 ߰ ν 95% ̻ ȿ ִ. ̴ 2 ̻ ̻Ӹ ƴ϶ ̷ οԵ ȿ ִ. ۿ ߿̳ , ֻ Ÿ.
Ȱ ̵
A 뺯κ 汸 Ǵ ȯ̱ ߿ϴ. Ϲ A ̷ 85 ̻ 1и ص ðų ϴ ϴ. ȭ Ŀ Ŀ ݵ Ĵ ͵ 濡 ߿ϴ. A ų Ȱ ϴ 쿡 鿪 ۷κҸ ֻ縦 ϴ 濡 ū ȴ.
̿
A ܹ̰ ȴ.